Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis
Background: Tubular carcinoma (TC) is a low proliferative grade 1 (G1) breast cancer (BC). Despite its favorable outcome and allegedly lower aggressiveness, patients are treated like other luminal G1 BC, with radiotherapy (RT) and hormonal therapy (HT). We performed: (1) a retrospective study compar...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.653388/full |
id |
doaj-735270c4fc3c467990aa28da8ed3497b |
---|---|
record_format |
Article |
spelling |
doaj-735270c4fc3c467990aa28da8ed3497b2021-04-29T11:06:00ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-04-011110.3389/fonc.2021.653388653388Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-AnalysisJasna Metovic0Alberto Bragoni1Simona Osella-Abate2Fulvio Borella3Chiara Benedetto4Maria Rosaria Gualano5Elena Olivero6Giacomo Scaioli7Roberta Siliquini8Pietro Maria Ferrando9Luca Bertero10Anna Sapino11Anna Sapino12Paola Cassoni13Isabella Castellano14Department of Oncology, University of Turin, Turin, ItalyPathology Unit, Department of Medical Sciences, University of Turin, Turin, ItalyPathology Unit, Department of Medical Sciences, University of Turin, Turin, ItalyDepartment of Surgical Sciences, Gynecology and Obstetrics 1, University of Turin, Turin, ItalyDepartment of Surgical Sciences, Gynecology and Obstetrics 1, University of Turin, Turin, ItalyDepartment of Public Health and Paediatric Sciences, University of Turin, Turin, ItalyDepartment of Public Health and Paediatric Sciences, University of Turin, Turin, ItalyDepartment of Public Health and Paediatric Sciences, University of Turin, Turin, ItalyDepartment of Public Health and Paediatric Sciences, University of Turin, Turin, ItalyPlastic Surgery Unit, Department of General and Specialistic Surgery, Città della Salute e della Scienza Hospital, Turin, ItalyPathology Unit, Department of Medical Sciences, University of Turin, Turin, ItalyPathology Unit, Department of Medical Sciences, University of Turin, Turin, ItalyPathology Division, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyPathology Unit, Department of Medical Sciences, University of Turin, Turin, ItalyPathology Unit, Department of Medical Sciences, University of Turin, Turin, ItalyBackground: Tubular carcinoma (TC) is a low proliferative grade 1 (G1) breast cancer (BC). Despite its favorable outcome and allegedly lower aggressiveness, patients are treated like other luminal G1 BC, with radiotherapy (RT) and hormonal therapy (HT). We performed: (1) a retrospective study comparing a TC cohort and a control series of luminal G1 BC and (2) a systematic review and meta-analysis focused on TC outcome.Materials and Methods: We selected a series of 572 G1 luminal BC patients [111 TC, 350 not otherwise specified (NOS), and 111 special-type (ST) BC] with follow-up and clinico-pathological data, who underwent local excision followed by RT at Città della Salute e della Scienza Hospital, Turin. Moreover, 22 and 13 studies were included in qualitative and quantitative meta-analysis, respectively.Results: TCs were generally smaller (≤10 mm) (P < 0.001), with lower lymph node involvement (P < 0.001). TCs showed no local and/or distant recurrences, while 16 NOS and 2 ST relapsed (P = 0.036). Kaplan–Meier curves confirmed more favorable TC outcome (DFI: log-rank test P = 0.03). Meta-analysis data, including the results of our study, showed that the pooled DFI rate was 96.4 and 91.8% at 5 and 10 years, respectively. Meta-regression analyses did not show a significant influence of RT nor HT on the DFI at 10 years.Conclusions: Compared to the other G1 BCs, TCs have an excellent outcome. The meta-analysis shows that TC recurrences are infrequent, and HT and RT have limited influence on prognosis. Hence, accurate diagnosis of TC subtype is critical to ensuring a tailored treatment approach.https://www.frontiersin.org/articles/10.3389/fonc.2021.653388/fulltubular carcinomameta-analysisprognosishormone treatmentradiotherapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jasna Metovic Alberto Bragoni Simona Osella-Abate Fulvio Borella Chiara Benedetto Maria Rosaria Gualano Elena Olivero Giacomo Scaioli Roberta Siliquini Pietro Maria Ferrando Luca Bertero Anna Sapino Anna Sapino Paola Cassoni Isabella Castellano |
spellingShingle |
Jasna Metovic Alberto Bragoni Simona Osella-Abate Fulvio Borella Chiara Benedetto Maria Rosaria Gualano Elena Olivero Giacomo Scaioli Roberta Siliquini Pietro Maria Ferrando Luca Bertero Anna Sapino Anna Sapino Paola Cassoni Isabella Castellano Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis Frontiers in Oncology tubular carcinoma meta-analysis prognosis hormone treatment radiotherapy |
author_facet |
Jasna Metovic Alberto Bragoni Simona Osella-Abate Fulvio Borella Chiara Benedetto Maria Rosaria Gualano Elena Olivero Giacomo Scaioli Roberta Siliquini Pietro Maria Ferrando Luca Bertero Anna Sapino Anna Sapino Paola Cassoni Isabella Castellano |
author_sort |
Jasna Metovic |
title |
Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis |
title_short |
Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis |
title_full |
Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis |
title_fullStr |
Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis |
title_full_unstemmed |
Clinical Relevance of Tubular Breast Carcinoma: Large Retrospective Study and Meta-Analysis |
title_sort |
clinical relevance of tubular breast carcinoma: large retrospective study and meta-analysis |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-04-01 |
description |
Background: Tubular carcinoma (TC) is a low proliferative grade 1 (G1) breast cancer (BC). Despite its favorable outcome and allegedly lower aggressiveness, patients are treated like other luminal G1 BC, with radiotherapy (RT) and hormonal therapy (HT). We performed: (1) a retrospective study comparing a TC cohort and a control series of luminal G1 BC and (2) a systematic review and meta-analysis focused on TC outcome.Materials and Methods: We selected a series of 572 G1 luminal BC patients [111 TC, 350 not otherwise specified (NOS), and 111 special-type (ST) BC] with follow-up and clinico-pathological data, who underwent local excision followed by RT at Città della Salute e della Scienza Hospital, Turin. Moreover, 22 and 13 studies were included in qualitative and quantitative meta-analysis, respectively.Results: TCs were generally smaller (≤10 mm) (P < 0.001), with lower lymph node involvement (P < 0.001). TCs showed no local and/or distant recurrences, while 16 NOS and 2 ST relapsed (P = 0.036). Kaplan–Meier curves confirmed more favorable TC outcome (DFI: log-rank test P = 0.03). Meta-analysis data, including the results of our study, showed that the pooled DFI rate was 96.4 and 91.8% at 5 and 10 years, respectively. Meta-regression analyses did not show a significant influence of RT nor HT on the DFI at 10 years.Conclusions: Compared to the other G1 BCs, TCs have an excellent outcome. The meta-analysis shows that TC recurrences are infrequent, and HT and RT have limited influence on prognosis. Hence, accurate diagnosis of TC subtype is critical to ensuring a tailored treatment approach. |
topic |
tubular carcinoma meta-analysis prognosis hormone treatment radiotherapy |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.653388/full |
work_keys_str_mv |
AT jasnametovic clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT albertobragoni clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT simonaosellaabate clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT fulvioborella clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT chiarabenedetto clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT mariarosariagualano clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT elenaolivero clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT giacomoscaioli clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT robertasiliquini clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT pietromariaferrando clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT lucabertero clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT annasapino clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT annasapino clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT paolacassoni clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis AT isabellacastellano clinicalrelevanceoftubularbreastcarcinomalargeretrospectivestudyandmetaanalysis |
_version_ |
1721501284697112576 |